These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19695372)

  • 1. [Opiate replacement therapy in France].
    Gatignol C
    Ann Pharm Fr; 2009 Sep; 67(5):360-4. PubMed ID: 19695372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Opiate replacement therapy in France: assessment of the public policies].
    Chast F
    Ann Pharm Fr; 2009 Sep; 67(5):299-303. PubMed ID: 19695365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opiate substitution: the users' point of view].
    Chappard P
    Ann Pharm Fr; 2009 Sep; 67(5):365-8. PubMed ID: 19695373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opioid substitution therapy in France: a physician's overview].
    Michel L
    Ann Pharm Fr; 2009 Sep; 67(5):369-73. PubMed ID: 19695374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of drug consumption among ambulatory patients in a drug agency of Northern France (Lens)].
    Brunelle E
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S15-23. PubMed ID: 12910030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative evaluation of sharing practices of materials at risk for infectious virus contamination by intravenous opiate users seeking treatment--application of the RAB(Risk for AIDS Behavior) self-administered questionnaire].
    Bertorelle V; Auriacombe M; Grabot D; Franques P; Martin C; Daulouede JP; Tignol J
    Encephale; 2000; 26(3):3-7. PubMed ID: 10951900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of measures taken in France to reduce the risks of heroin addiction via intravenous route].
    Henrion R
    Bull Acad Natl Med; 1997; 181(6):1177-85; discussion 1186-9. PubMed ID: 9453840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses.
    Strang J; Manning V; Mayet S; Best D; Titherington E; Santana L; Offor E; Semmler C
    Addiction; 2008 Oct; 103(10):1648-57. PubMed ID: 18821875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why buprenorphine is so successful in treating opiate addiction in France.
    Fatseas M; Auriacombe M
    Curr Psychiatry Rep; 2007 Oct; 9(5):358-64. PubMed ID: 17915074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
    Aasland OG; Spilhaug G; Johannesen A
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of drug addiction in France (a short history)].
    Chossegros P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S44-50. PubMed ID: 17965635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004].
    Frauger E; Vigneau C; Orléans V; Thirion X; Jolliet P; Micallef J; Réseau des CEIP
    Therapie; 2008; 63(2):119-27. PubMed ID: 18561886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of enforcement controlled substance laws in health policy for prescribing opiate medications: a painful assessment of morbidity and mortality.
    Miller NS
    Am J Ther; 2006; 13(6):527-33. PubMed ID: 17122534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines submitted to narcotics regulations in France, 1992-2007.
    Baumevieille M; Daveluy A; Maurain C; Bégaud B; Haramburu F
    Fundam Clin Pharmacol; 2009 Jun; 23(3):345-9. PubMed ID: 19453761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopathology of the misuse of Subutex®: The Popeye syndrome].
    Békaert J; Podevin G
    Encephale; 2015 Jun; 41(3):229-37. PubMed ID: 25212472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The making of the chronic addict.
    Järvinen M; Andersen D
    Subst Use Misuse; 2009; 44(6):865-85. PubMed ID: 19444727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent evolution in opiate dependence in France during generalisation of maintenance treatments.
    Thirion X; Micallef J; Barrau K; Djezzar S; Lambert H; Sanmarco JL; Lagier G
    Drug Alcohol Depend; 2001 Feb; 61(3):281-5. PubMed ID: 11164692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.